141 related articles for article (PubMed ID: 32019671)
1. Utility of synthetic MRI in predicting the Ki-67 status of oestrogen receptor-positive breast cancer: a feasibility study.
Matsuda M; Kido T; Tsuda T; Okada K; Shiraishi Y; Suekuni H; Kamei Y; Kitazawa R; Mochizuki T
Clin Radiol; 2020 May; 75(5):398.e1-398.e8. PubMed ID: 32019671
[TBL] [Abstract][Full Text] [Related]
2. Utility of synthetic MRI in predicting pathological complete response of various breast cancer subtypes prior to neoadjuvant chemotherapy.
Matsuda M; Fukuyama N; Matsuda T; Kikuchi S; Shiraishi Y; Takimoto Y; Kamei Y; Kurata M; Kitazawa R; Kido T
Clin Radiol; 2022 Nov; 77(11):855-863. PubMed ID: 36055826
[TBL] [Abstract][Full Text] [Related]
3. Triple-negative breast cancer on contrast-enhanced MRI and synthetic MRI: A comparison with non-triple-negative breast carcinoma.
Matsuda M; Tsuda T; Ebihara R; Toshimori W; Okada K; Takeda S; Okumura A; Shiraishi Y; Suekuni H; Kamei Y; Kurata M; Kitazawa R; Mochizuki T; Kido T
Eur J Radiol; 2021 Sep; 142():109838. PubMed ID: 34217136
[TBL] [Abstract][Full Text] [Related]
4. Investigation of synthetic MRI with quantitative parameters for discriminating axillary lymph nodes status in invasive breast cancer.
Qu M; Feng W; Liu X; Li Z; Li Y; Lu X; Lei J
Eur J Radiol; 2024 Jun; 175():111452. PubMed ID: 38604092
[TBL] [Abstract][Full Text] [Related]
5. DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.
Fan M; Cheng H; Zhang P; Gao X; Zhang J; Shao G; Li L
J Magn Reson Imaging; 2018 Jul; 48(1):237-247. PubMed ID: 29219225
[TBL] [Abstract][Full Text] [Related]
6. Differences in tumour heterogeneity based on dynamic contrast-enhanced MRI between tumour and peritumoural stroma for predicting Ki-67 status of invasive ductal carcinoma.
He X; Zhou J; Ye S; Cheng Q; Miao H; Xu N; Li J; Pan Z; Cheng J; Wang M
Clin Radiol; 2021 Jun; 76(6):470.e13-470.e22. PubMed ID: 33648758
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.
Shin JK; Kim JY
J Magn Reson Imaging; 2017 Jan; 45(1):94-102. PubMed ID: 27313102
[TBL] [Abstract][Full Text] [Related]
8. Synthetic MRI in breast cancer: differentiating benign from malignant lesions and predicting immunohistochemical expression status.
Li X; Fan Z; Jiang H; Niu J; Bian W; Wang C; Wang Y; Zhang R; Zhang H
Sci Rep; 2023 Oct; 13(1):17978. PubMed ID: 37864025
[TBL] [Abstract][Full Text] [Related]
9. Synthetic MRI with quantitative mappings for identifying receptor status, proliferation rate, and molecular subtypes of breast cancer.
Gao W; Yang Q; Li X; Chen X; Wei X; Diao Y; Zhang Y; Chen C; Guo B; Wang Y; Lei Z; Zhang S
Eur J Radiol; 2022 Mar; 148():110168. PubMed ID: 35078137
[TBL] [Abstract][Full Text] [Related]
10. An MRI-based Radiomics Classifier for Preoperative Prediction of Ki-67 Status in Breast Cancer.
Liang C; Cheng Z; Huang Y; He L; Chen X; Ma Z; Huang X; Liang C; Liu Z
Acad Radiol; 2018 Sep; 25(9):1111-1117. PubMed ID: 29428211
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRI.
Meng T; He N; He H; Liu K; Ke L; Liu H; Zhong L; Huang C; Yang A; Zhou C; Qian L; Xie C
Cancer Imaging; 2020 Dec; 20(1):88. PubMed ID: 33317609
[TBL] [Abstract][Full Text] [Related]
12. Predicting of Ki-67 Expression Level Using Diffusion-Weighted and Synthetic Magnetic Resonance Imaging in Invasive Ductal Breast Cancer.
Zhang L; Hao J; Guo J; Zhao X; Yin X
Breast J; 2023; 2023():6746326. PubMed ID: 37063453
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of Quantitative MRI Using 3D-QALAS for Discriminating Immunohistochemical Status in Invasive Ductal Carcinoma of the Breast.
Amano M; Fujita S; Takei N; Sano K; Wada A; Sato K; Kikuta J; Kuwatsuru Y; Tachibana R; Sekine T; Horimoto Y; Aoki S
J Magn Reson Imaging; 2023 Dec; 58(6):1752-1759. PubMed ID: 36951614
[TBL] [Abstract][Full Text] [Related]
14. Texture analysis using non-contrast MRI to predict estrogen receptor status in breast cancer lesions: Is it feasible?
Shokeir FA; Elmokadem AH; Soliman N; Khater A; Bayoumi D
Clin Radiol; 2024 Jul; 79(7):e892-e899. PubMed ID: 38719689
[TBL] [Abstract][Full Text] [Related]
15. In vivo biochemical 7.0 Tesla magnetic resonance: preliminary results of dGEMRIC, zonal T2, and T2* mapping of articular cartilage.
Welsch GH; Mamisch TC; Hughes T; Zilkens C; Quirbach S; Scheffler K; Kraff O; Schweitzer ME; Szomolanyi P; Trattnig S
Invest Radiol; 2008 Sep; 43(9):619-26. PubMed ID: 18708855
[TBL] [Abstract][Full Text] [Related]
16. Association among T2 signal intensity, necrosis, ADC and Ki-67 in estrogen receptor-positive and HER2-negative invasive ductal carcinoma.
Kim SY; Kim EK; Moon HJ; Yoon JH; Koo JS; Kim SG; Kim MJ
Magn Reson Imaging; 2018 Dec; 54():176-182. PubMed ID: 30172938
[TBL] [Abstract][Full Text] [Related]
17. Correlation between the dynamic contrast-enhanced MRI features and prognostic factors in breast cancer: A retrospective case-control study.
Tao W; Hu C; Bai G; Zhu Y; Zhu Y
Medicine (Baltimore); 2018 Jul; 97(28):e11530. PubMed ID: 29995825
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Values from Synthetic MRI Correlate with Breast Cancer Subtypes.
Kazama T; Takahara T; Kwee TC; Nakamura N; Kumaki N; Niikura N; Niwa T; Hashimoto J
Life (Basel); 2022 Aug; 12(9):. PubMed ID: 36143344
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
[TBL] [Abstract][Full Text] [Related]
20. The role of MRI in predicting Ki-67 in breast cancer: preliminary results from a prospective study.
Caiazzo C; Di Micco R; Esposito E; Sollazzo V; Cervotti M; Varelli C; Forestieri P; Limite G
Tumori; 2018 Dec; 104(6):438-443. PubMed ID: 28478644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
